medical-device-investing Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
medical-device-investing Precision Therapeutics Announces Record STREAMWAY System Sales in the First Three Months of 2018
pharmaceutical-investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
medical-device-investing Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System
